CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nu

CSPC Pharmaceutical Earlier Announced Strategic Research Collaboration, Option, License Agreement With AstraZeneca To Develop Novel Small Nucleic Acid Drug Candidates Using Proprietary SiRNA Drug Discovery And Extrahepatic Targeted Delivery Platforms